Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIPRETINIB vs RISPERDAL CONSTA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIPRETINIB vs RISPERDAL CONSTA: Safety Overview

Metric RIPRETINIB RISPERDAL CONSTA
Total FAERS Reports 4,432 140
Deaths Reported 465 29
Death Rate 10.5% 20.7%
Hospitalizations 948 56
Average Patient Age 66.8 yrs 45.0 yrs
% Female Patients 45.3% N/A
FDA Approval Date May 15, 2020 N/A
Manufacturer Deciphera Pharmaceuticals, LLC N/A
Route ORAL N/A
Marketing Status Prescription N/A